{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Reviva Pharmaceuticals Holdings, Inc."},"Symbol":{"label":"Symbol","value":"RVPHW"},"Address":{"label":"Address","value":"19925 STEVENS CREEK BOULEVARD,SUITE 100, CUPERTINO, California, 95014, United States"},"Phone":{"label":"Phone","value":"+1 408 501-8881"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Reviva Pharmaceuticals Holdings Inc is a clinical-stage biopharmaceutical company. It is developing a portfolio of internally discovered therapies that address unmet medical needs in the areas of central nervous system, respiratory, and metabolic diseases. The company is currently focused on the development of its lead product candidate, RP5063, which targets schizophrenia, bipolar disorder, major depressive disorder, behavioral & psychotic symptoms, dementia or Alzheimer's disease, Parkinson's disease psychosis, attention deficit hyperactivity disorder, and also respiratory indications such as pulmonary arterial hypertension & idiopathic pulmonary fibrosis."},"CompanyUrl":{"label":"Company Url","value":"https://www.revivapharma.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Laxminarayan Bhat","title":"President, Chief Executive Officer & Director"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}